National Influenza Centre, Sciensano, Brussels, Belgium.
European Public Health Microbiology Training Programme (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Euro Surveill. 2023 Jul;28(29). doi: 10.2807/1560-7917.ES.2023.28.29.2300056.
BackgroundKnowledge on the burden attributed to influenza viruses vs other respiratory viruses in children hospitalised with severe acute respiratory infections (SARI) in Belgium is limited.AimThis observational study aimed at describing the epidemiology and assessing risk factors for severe disease.MethodsWe retrospectively analysed data from routine national sentinel SARI surveillance in Belgium. Respiratory specimens collected during winter seasons 2011 to 2020 were tested by multiplex real-time quantitative PCR (RT-qPCR) for influenza and other respiratory viruses. Demographic data and risk factors were collected through questionnaires. Patients were followed-up for complications or death during hospital stay. Analysis focused on children younger than 15 years. Binomial logistic regression was used to identify risk factors for severe disease in relation to infection status.ResultsDuring the winter seasons 2011 to 2020, 2,944 specimens met the study case definition. Complications were more common in children with underlying risk factors, especially asthma (adjusted risk ratio (aRR): 1.87; 95% confidence interval (CI): 1.46-2.30) and chronic respiratory disease (aRR: 1.88; 95% CI: 1.44-2.32), regardless of infection status and age. Children infected with non-influenza respiratory viruses had a 32% higher risk of complications (aRR: 1.32; 95% CI: 1.06-1.66) compared with children with influenza only.ConclusionMulti-virus testing in children with SARI allows a more accurate assessment of the risk of complications and attribution of burden to respiratory viruses beyond influenza. Children with asthma and respiratory disease should be prioritised for clinical care, regardless of their virological test result and age, and targeted for prevention campaigns.
背景知识 关于在比利时因严重急性呼吸道感染(SARI)住院的儿童中,流感病毒与其他呼吸道病毒的负担,目前知之甚少。
目的 本观察性研究旨在描述流行病学,并评估严重疾病的危险因素。
方法 我们回顾性分析了比利时常规国家哨点 SARI 监测的数据。在 2011 年至 2020 年的冬季季节,通过多重实时定量 PCR(RT-qPCR)对呼吸道标本进行流感和其他呼吸道病毒检测。通过问卷调查收集人口统计学数据和危险因素。在住院期间对患者进行并发症或死亡随访。分析集中在 15 岁以下的儿童。二项逻辑回归用于确定感染状态与严重疾病之间的危险因素。
结果 在 2011 年至 2020 年的冬季季节,有 2944 个标本符合研究病例定义。有潜在危险因素的儿童并发症更为常见,尤其是哮喘(调整后的风险比(aRR):1.87;95%置信区间(CI):1.46-2.30)和慢性呼吸道疾病(aRR:1.88;95%CI:1.44-2.32),无论感染状态和年龄如何。与仅感染流感的儿童相比,感染非流感呼吸道病毒的儿童并发症风险高 32%(aRR:1.32;95%CI:1.06-1.66)。
结论 在 SARI 患儿中进行多病毒检测可以更准确地评估并发症风险,并归因于流感以外的呼吸道病毒。无论其病毒学检测结果和年龄如何,哮喘和呼吸道疾病患儿应优先进行临床护理,并应针对预防活动进行重点关注。